Diazyme Laboratories Secures FDA Clearance for Lp(a) Assay
POWAY, Calif., June 17, 2026 Diazyme Laboratories, Inc. has received U.S. FDA 510(k) clearance for its Lipoprotein(a) [Lp(a)] Molarity...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
POWAY, Calif., June 17, 2026 Diazyme Laboratories, Inc. has received U.S. FDA 510(k) clearance for its Lipoprotein(a) [Lp(a)] Molarity...
PARSIPPANY, N.J., June 8, 2026 Onkos Surgical announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...
MILFORD, Massachusetts, USA – June 3, 2026 Waters Corporation has announced U.S. Food and Drug Administration (FDA) 510(k) clearance...
PALO ALTO, Calif., May 14, 2026 Glooko, Inc. announced that the U.S. Food and Drug Administration has granted 510(k)...
CHARLOTTESVILLE, Va., May 7, 2026 RIVANNA announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...
ATLANTA, Feb. 23, 2026 — MiRus announced U.S. FDA 510(k) clearance and commercial launch of the IO™ Expandable Wedge...
PALO ALTO, USA & MULGRAVE, Australia, Feb. 20, 2026 — Gyder Surgical announced the first commercial surgical cases in...
PARMA, ITALY — February 17, 2026 Copan Diagnostics announced that its AI-enabled microbiology imaging system PhenoMATRIX has received U.S....
WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 Retia Medical has received U.S. FDA 510(k) clearance for...
ROSWELL, Ga., Feb. 12, 2026 — StimLabs announced that the U.S. Food and Drug Administration has granted 510(k) clearance...
